0001209191-23-023829.txt : 20230407
0001209191-23-023829.hdr.sgml : 20230407
20230407171228
ACCESSION NUMBER: 0001209191-23-023829
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20230407
DATE AS OF CHANGE: 20230407
EFFECTIVENESS DATE: 20230407
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALIMERA SCIENCES INC
CENTRAL INDEX KEY: 0001267602
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 200028718
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-478298
FILM NUMBER: 23809222
BUSINESS ADDRESS:
STREET 1: 6310 TOWN SQUARE
STREET 2: SUITE 400
CITY: ALPHARETTA
STATE: GA
ZIP: 30005
BUSINESS PHONE: 678-990-5740
MAIL ADDRESS:
STREET 1: 6310 TOWN SQUARE
STREET 2: SUITE 400
CITY: ALPHARETTA
STATE: GA
ZIP: 30005
D
1
primary_doc.xml
X0708
D
LIVE
0001267602
ALIMERA SCIENCES INC
6310 Town Square
Suite 400
Alpharetta
GA
GEORGIA
30005
(678) 990-5740
DELAWARE
None
None
Corporation
true
Richard
S.
Eiswirth, Jr.
6310 Town Square
Suite 400
Alpharetta
GA
GEORGIA
30005
Executive Officer
Director
Philip
Ashman
6310 Town Square
Suite 400
Alpharetta
GA
GEORGIA
30005
Executive Officer
David
Holland
6310 Town Square
Suite 400
Alpharetta
GA
GEORGIA
30005
Executive Officer
Russell
Skibsted
6310 Town Square
Suite 400
Alpharetta
GA
GEORGIA
30005
Executive Officer
Garheng
Kong
6310 Town Square
Suite 400
Alpharetta
GA
GEORGIA
30005
Director
James
R.
Largent
6310 Town Square
Suite 400
Alpharetta
GA
GEORGIA
30005
Director
Daniel
Myers
6310 Town Square
Suite 400
Alpharetta
GA
GEORGIA
30005
Director
Erin
Parsons
6310 Town Square
Suite 400
Alpharetta
GA
GEORGIA
30005
Director
Peter
J.
Pizzo III
6310 Town Square
Suite 400
Alpharetta
GA
GEORGIA
30005
Director
Roger
Sawheny
6310 Town Square
Suite 400
Alpharetta
GA
GEORGIA
30005
Director
John
Snisarenko
6310 Town Square
Suite 400
Alpharetta
GA
GEORGIA
30005
Director
Pharmaceuticals
$25,000,001 - $100,000,000
- 06b
false
2023-03-24
false
true
true
true
false
0
27000000
12000000
15000000
Total Offering Amount consists of two tranches. Tranche one represented $12,000,000 of securities and tranche two represents an additional $15,000,000 of securities that may be sold on agreement between the Issuer and a majority of tranche one investors.
false
4
0
0
0
false
ALIMERA SCIENCES INC
/s/ Richard S. Eiswirth, Jr.
Richard S. Eiswirth, Jr.
Chief Executive Officer
2023-04-07